Related Experiment Video
Updated: Apr 7, 2026
Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis
Published on: May 26, 2021
Somatic Mutations and Clonal Hematopoiesis in Aplastic Anemia
Tetsuichi Yoshizato1, Bogdan Dumitriu, Kohei Hosokawa
1From the Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto (T.Y., K.Y., A.S.-O., Y. Sato, H.S., K.K., Y. Shiozawa, Y.N., A.K., M.S., S.O.), Department of Cellular Transplantation Biology, Division of Cancer Medicine, Graduate School of Medical Sciences, Kanazawa University, Kanazawa (K.H., T.K., S.N.), Laboratory of DNA Information Analysis, Human Genome Center, Institute of Medical Science, University of Tokyo, Tokyo (Y. Shiraishi, K.C., H.T., S.M.), and the Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya (Y.O.) - all in Japan; the Hematology Branch (B.D., K.H., D.T., D.L., P.S., N.S.Y.) and Office of Biostatistics Research (C.O.W.), National Heart, Lung, and Blood Institute, Bethesda, MD; and the Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland (H.M., M.J.C., J.P.M.).
Clonal hematopoiesis is common in aplastic anemia, with specific mutations impacting patient outcomes. These somatic mutations, often age-related, show variable clonal dynamics and unpredictable clinical impact.
Area of Science:
- Hematology
- Genetics
- Oncology
Background:
- Acquired aplastic anemia involves immune-mediated destruction of hematopoietic cells, leading to pancytopenia.
- While immunosuppressive therapy is effective, a significant percentage of patients develop myelodysplastic syndromes or acute myeloid leukemia.
- These secondary malignancies typically manifest months to years post-aplastic anemia diagnosis.
Purpose of the Study:
- To investigate the prevalence and clinical significance of clonal hematopoiesis in acquired aplastic anemia.
- To analyze the impact of somatic mutations on treatment response and patient survival.
- To understand the dynamics of clonal evolution in the context of aplastic anemia.
Main Methods:
- Next-generation sequencing and array-based karyotyping were performed on blood samples from 439 aplastic anemia patients.
- Serial samples from 82 patients were analyzed to track clonal dynamics over time.
- Somatic mutations in myeloid cancer candidate genes were identified and characterized.
Main Results:
- Clonal hematopoiesis was detected in 47% of patients, frequently involving acquired mutations with an age-related signature.
- Somatic mutations were present in one-third of patients, often in limited genes at low variant allele frequency.
- Mutations in PIGA, BCOR, and BCORL1 correlated with better treatment response and survival, while DNMT3A and ASXL1 mutations were associated with worse outcomes.
- Clonal dynamics exhibited high variability and were not always predictive of individual patient outcomes.
Conclusions:
- Clonal hematopoiesis is a prevalent feature in acquired aplastic anemia.
- Specific somatic mutations are associated with distinct clinical outcomes, influencing survival and treatment response.
- The observed mutation patterns suggest Darwinian selection within the bone marrow microenvironment.
- Somatic clone evolution in aplastic anemia patients is highly variable and often unpredictable.
Related Concept Videos
01:22Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
01:01Regulation of Hematopoietic Stem Cells
01:21Hematopoiesis
02:21Cancers Originate from Somatic Mutations in a Single Cell
02:21Cancers Originate from Somatic Mutations in a Single Cell
01:19Multipotency of Hematopoietic Stem Cells